4Cuenod C,Leconte I,Siauve N,et al.Early changes in liver perfusion caused by occult metastases in rats:detection with quantitative CT[J].Radiology,2001,218:556.
5Platt JF,Francis IR,Ellis JH,et al.Liver metastases:early detection based on abnormal contrast material enhancement at dual-phase helical CT[J].Radiology,1997,205:49.
6Sheafor DH,Killius JS,Paulson EK,et al.Hepatic parenchymal enhancement during triplephase helical CT:can it be used to predict which patients with breast cancer will develop hepatic metastases?[J].Radiology,2000,214:875.
7Bell SD,Peter AM.Measurement of the blood flow from frist-pass traionuclide angiography:Influence of bolus volume[J].Eur J Nucl Med,1991,18(11):885.
8Dugdale PE,Miles KA.Hepatic metastases:the value of quantitative assessment of contrast enhancement on computed tomography[J].Eur J Radiol,2000,21:462.
9Miles KA.Perfusion CT for the assessment of tumour vascularity:which protocol[J].Bri J Radiol,2003,S36.
10Young SW,Turner RJ,Castellino RA,et al.A strategy for the contrast enhancement of malignant tumors using dynamic computed tomography and intravascular pharmacokinetics[J].Radiology,1980,137(1pt1):137.
